Cystic fibrosis gene therapy

Area of Science:

• * Gene therapy for genetic disorders
• * Molecular biology and virology

Background:

• * Cystic fibrosis (CF) is a genetic disorder affecting chloride ion transport.
• * Gene therapy aims to correct the underlying genetic defect in CF.
• * Various viral and non-viral delivery systems are under investigation.

Purpose of the Study:

• * To review current cystic fibrosis gene therapy approaches.
• * To assess the safety and efficacy of different gene delivery vectors.
• * To highlight the progress of liposomal and adenoviral vectors.

Main Methods:

• * Evaluation of viral vectors: adenovirus, retrovirus, adeno-associated virus.
• * Assessment of non-viral vectors: liposomes, receptor-mediated endocytosis.
• * Review of in vivo studies demonstrating correction of the CF defect.

Main Results:

• * Multiple gene therapy strategies are being evaluated for cystic fibrosis.
• * Liposomal and adenoviral vector trials are the most advanced.
• * Both liposomal and adenoviral vectors have demonstrated in vivo correction of the CF Cl- conductance defect.

Conclusions:

• * Gene therapy holds potential for treating cystic fibrosis.
• * Liposomal and adenoviral vectors represent promising therapeutic strategies.
• * Further research is warranted to optimize safety and efficacy for clinical application.